8-K: Ontrak Health Reports Q4 and Year-End 2024 Financial Results; Announces New Customer Partnership and Contract Extension

Ontrak Health announces its Q4 and full-year 2024 financial results, highlighting revenue declines but improvements in operating and adjusted EBITDA losses, along with new customer partnerships and contract extensions.

Summary

• Ontrak Health reported a Q4 2024 revenue of $3.1 million, an 11% decrease year-over-year.
• Full-year 2024 revenue was $10.8 million, a 15% decrease from the previous year.
• The Q4 operating loss was $(4.4) million, a 16% decrease year-over-year, while the full-year operating loss was $(17.8) million, also a 16% decrease.
• Q4 Adjusted EBITDA was $(2.8) million, a 20% improvement year-over-year, and full-year Adjusted EBITDA was $(12.8) million, a 13% improvement.
• The company announced a new customer partnership with Intermountain Health for Medicare Advantage members.
• A three-year contract extension with Sentara Health Plans was also announced, following expansions in 2024.
• For Q1 2025, the company estimates revenue in the range of $2.0 million to $2.3 million.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company highlights improvements in operating loss and adjusted EBITDA, the revenue decline and net losses are concerning. New partnerships and contract extensions offer some optimism, but the overall financial performance is mixed.

Positives

• Operating loss and Adjusted EBITDA showed improvements year-over-year for both Q4 and the full year.
• The company secured a new customer partnership with Intermountain Health.
• Ontrak extended its contract with Sentara Health Plans for three years.
• The launch of the WholeHealth+ solution with Intermountain Health is off to a strong start.
• There is encouraging engagement with the Northeast Regional Plan.
• A large Midwest plan in the pipeline holds the potential to more than double the company's run-rate revenue.

Negatives

• Revenue decreased by 11% in Q4 and 15% for the full year.
• The company experienced a net loss of $(5.2) million in Q4 and $(25.5) million for the full year.
• Total enrolled members in the WholeHealth+ program decreased from 1,758 at the end of Q4 2023 to 1,409 at the end of Q4 2024.
• One health plan customer, representing 59.5% of the company's total revenue in 2024 ($6.5 million), did not continue using the company's services after December 2024.

Risks

• The company's ability to successfully execute its strategy and business plan is a risk.
• Increasing revenue, managing expenses, and achieving profitability are ongoing challenges.
• High customer concentration poses a risk due to the ability of customers to terminate contracts.
• The company's ability to maintain its Nasdaq listing is a risk.
• The federal jury's conviction of the company's largest stockholder and former CEO and Chairman could lead to further investigations or proceedings.
• The company faces intense competition and competitive pressures in its industry.

Future Outlook

The company estimates revenue for the quarter ending March 31, 2025, to be in the range of $2.0 million to $2.3 million.

Management Comments

• Brandon LaVerne, Ontrak Health's CEO, stated that they are pleased with the progress in securing new customers, expanding existing relationships, and building their pipeline.
• He noted the strong start of the WholeHealth+ solution with Intermountain Health and encouraging engagement with the Northeast Regional Plan.
• LaVerne mentioned that a large Midwest plan in the pipeline holds the potential to more than double their run-rate revenue.

Industry Context

Ontrak operates in the behavioral healthcare industry, which is increasingly focused on AI-powered and technology-enabled solutions. The company's partnerships and contract extensions indicate a growing demand for integrated physical and behavioral health solutions. Competitors in this space include companies offering telehealth, mental health support, and chronic disease management programs. The focus on value-based care and addressing social determinants of health aligns with broader industry trends.

Comparison to Industry Standards

• It's difficult to directly compare Ontrak's results without knowing the specific details of their contracts and the populations they serve.
• However, similar companies in the digital health space, such as Teladoc Health or Amwell, often report higher revenue figures, but also operate at a larger scale.
• Ontrak's focus on behavioral health and integration with physical health aligns with industry trends, but their financial performance needs improvement to be competitive with larger players.
• For example, Teladoc Health reported revenue of $2.4 billion in 2023, while Amwell reported revenue of $277 million, both significantly higher than Ontrak's $10.8 million.

Stakeholder Impact

• Shareholders may be concerned about the revenue decline and net losses, but encouraged by the improvements in operating loss and adjusted EBITDA.
• Employees may be affected by the company's cost-saving measures and workforce reductions.
• Customers (health plans and members) may benefit from the company's expanded partnerships and service offerings.
• Suppliers and creditors may be impacted by the company's financial performance and ability to meet its obligations.

Next Steps

• The company will host a conference call and webcast to discuss the financial results.
• Ontrak will focus on converting its pipeline of prospects into active customers.
• The company will continue to execute on its strategy and business plan to increase revenue and achieve profitability.

Key Dates

Keywords

behavioral healthcare, AI-powered, technology-enabled, financial results, revenue, EBITDA, customer partnership, contract extension, Ontrak Health, OTRK